Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » Peter MacCallum Cancer Centre – Recruiting NET health professionals for International Delphi survey

Peter MacCallum Cancer Centre – Recruiting NET health professionals for International Delphi survey

  • July 21, 2022

Recruiting NET health professionals for International Delphi survey

Development of a neuroendocrine tumour (NET) nutrition-risk screening tool to identify patients requiring nutrition intervention and education

Multidisciplinary health professionals are invited to take part in an online Delphi survey aiming to develop a novel NET-nutrition risk screening tool. The goal of this screening tool will be to identify NET patients requiring further nutrition assessment and support. Through the Delphi survey health professionals will be able to review and provide feedback on the tool and it’s development. Round One of the survey will be open until August 12th 2022. After development, the tool will be tested with a cohort of NET patients to measure it’s clinical utility ahead of plans for a larger validation study.

  

This study is being conducted by the NET unit and Nutrition and Speech Pathology Department at the Peter MacCallum Cancer Centre, Melbourne, Australia, led by Dr Erin Laing

If you would like to participate in this research study, please click the link provided to receive further information and start the survey.

Link for further information/survey:
https://redcap.link/netns_delphi1

 

Learn more here

Share this post

Recent posts

NECA CEO Meredith Cummins is Now INCA President

February 16, 2026

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

February 9, 2026

Raising Awareness for NETs on World Cancer Day in WA

February 4, 2026

Australia delivers excellent cancer care, but not equally

February 4, 2026
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousMolecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms
NextImpact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) AggressivenessNext

Related Posts

NECA CEO Meredith Cummins is Now INCA President

We are proud to share that our CEO, Meredith Cummins, has been appointed President of the International Neuroendocrine Cancer Alliance (INCA). Meredith has served on

NECA Contributes to Multidisciplinary Systemic Review

NECA was invited to participate and co-author in a multidisciplinary working group to conduct a systematic review and meta-analysis to evaluate the current evidence on

Celebrated Chef and Slow Food Pioneer Skye Gyngell Passed Away from Neuroendocrine Cancer

Australian born chef Skye Gyngell, one of the most influential voices in the slow food movement and a pioneer of seasonal, sustainable cooking, has died

NECA Christmas and New Year Closure Details

Ten tips during the holiday season. Neuroendocrine Cancer Australia advises holiday closure dates effective COB Tuesday 23 December 2025 to Friday 2 January 2026 inclusive.

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2026 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin